Status:
COMPLETED
Prescription Opioid Addiction Treatment Study (POATS)
Lead Sponsor:
Mclean Hospital
Collaborating Sponsors:
University of California, Los Angeles
Conditions:
Opiate Dependence
Substance-related Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether treatment outcome for subjects dependent on prescription opioid analgesics can be improved by adding individual drug counseling to the prescription of...
Detailed Description
This is a randomized 2-phase, open-label; multi-center study conducted in outpatient treatment settings. The main objective of this study is to identify an effective sublingual buprenorphine/naloxone ...
Eligibility Criteria
Inclusion
- 18 years old or older
- Physically dependent on opioids
- Meet DSM-IV criteria for opioid dependence
Exclusion
- Known allergy or sensitivity to buprenorphine or naloxone
- Unstable psychiatric disorder
- Pregnant or lactating females
- Liver function test results greater than 5 times the upper limit of normal range
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
653 Patients enrolled
Trial Details
Trial ID
NCT00316277
Start Date
May 1 2006
End Date
January 1 2013
Last Update
February 6 2013
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Integrated Substance Abuse Programs
Los Angeles, California, United States, 90025
2
San Francisco General Hospital
San Francisco, California, United States, 94110
3
East Indiana Treatment Center
Lawrenceburg, Indiana, United States, 47025
4
McLean Hospital, Alcohol and Drug Abuse Treatment Program
Belmont, Massachusetts, United States, 02478